Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 356 participants.
Also called NCT05128513
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 356 participants
- Registry
-
NCT05128513
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Suspended
Technical summary
Registry record NCT05128513. Randomized; single masking; primary purpose treatment. Start 2022-01-14 (actual); primary completion 2027-04-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke
- Condition
- Hemorrhagic Stroke
- Intervention (Device)
- DELP
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct05128513- Content hash
306b75edbdc450f574935bd9adc469666c206da276b44839b8ae1db601a9ced6